menu
    • menu

    Company profile for DBV Technologies

    NEW Drugs in Dev: 7
    Aspen API. More than just an API™

    Virtual Booth

    Contact Supplier

    Sharp is a leader in commercial packaging, clinical services, and sterile manufacturing.

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2026-01-12

    Virtual Booth

    Contact Supplier

    Suanfarma, at the Core of a Better Life.

    Virtual Booth

    Contact Supplier

    ChemWerth works in generic API development & supply, non-infringement patent strategy development and regulatory support.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-2026-02-09

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    REF. STANDARDS & IMPURITIES

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    DBV Technologies is a global clinical stage biopharmaceutical company founded by pediatricians and entrepreneurs who believed that food allergies could one day be treated safely and effectively. With this mission driving our commitment to the advancement of treatments in this field, we are investigating a potential new class of immunotherapy that aims to activate the immune system of patients through the skin.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    DBV TechnologiesFrance Flag
    Country
    Country
    France
    Address
    Address
    177-181 avenue Pierre Brossolette 92120 – Montrouge
    Telephone
    Telephone
    +33 (0)1 55 42 78 78
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.dbv-technologies.com/
    Linkedin
    Linkedin
    https://www.linkedin.com/company/dbv-technologies
    youtube
    YouTube
    Twitter
    Twitter
    https://x.com/dbvtechnologies?lang=en

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    ASPEN

    ASPEN

    Not Confirmed

    envelop Contact Supplier

    ASPEN

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    DBV to Present Phase 3 Viaskin Peanut Patch Data at AAAAI 2026
    DBV to Present Phase 3 Viaskin Peanut Patch Data at AAAAI 2026

    10 Feb 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/02/10/3235812/0/en/DBV-Technologies-to-Present-Additional-Data-from-the-VITESSE-Phase-3-Study-of-the-VIASKIN-Peanut-Patch-in-Children-Ages-4-7-Years-and-Discuss-Future-of-EPIT-in-the-Treatment-Landsc.html

    GLOBENEWSWIRE
    10 Feb 2026
    Share Share
    DBV Technologies Joins Guggenheim Biotech Summit
    DBV Technologies Joins Guggenheim Biotech Summit

    09 Feb 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/02/09/3234927/0/en/DBV-Technologies-to-Participate-in-the-Guggenheim-Securities-Emerging-Outlook-Biotech-Summit.html

    GLOBENEWSWIRE
    09 Feb 2026
    Share Share
    DBV Technologies Raises €166.7M From ABSA And BS Warrants
    DBV Technologies Raises €166.7M From ABSA And BS Warrants

    16 Jan 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/01/16/3220592/0/en/DBV-Technologies-Announces-166-7-Million-in-Gross-Proceeds-Following-the-Full-Exercise-of-the-ABSA-Warrants-and-BS-Warrants-Issued-on-its-March-2025-Financing.html

    GLOBENEWSWIRE
    16 Jan 2026
    Share Share
    Company Discloses Dec. Voting Rights, Share Data
    Company Discloses Dec. Voting Rights, Share Data

    12 Jan 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/01/12/3217339/0/en/Information-Regarding-the-Total-number-of-Voting-Rights-and-Total-Number-of-Shares-of-the-Company-as-of-December-31-2025.html

    GLOBENEWSWIRE
    12 Jan 2026
    Share Share
    ODDO BHF Releases Half-Year DBV Liquidity Report
    ODDO BHF Releases Half-Year DBV Liquidity Report

    07 Jan 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/01/07/3214879/0/en/Half-Year-Report-on-the-DBV-Technologies-Liquidity-Contract-with-ODDO-BHF.html

    GLOBENEWSWIRE
    07 Jan 2026
    Share Share
    Company Reports Voting Rights, Shares as of Dec. 31, 2025
    Company Reports Voting Rights, Shares as of Dec. 31, 2025

    05 Jan 2026

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2026/01/05/3213169/0/en/Information-Regarding-the-Total-Number-of-Voting-Rights-and-Total-Number-of-Shares-of-the-Company-as-of-December-31-2025.html

    GLOBENEWSWIRE
    05 Jan 2026
    Share Share

    REF. STANDARDS & IMPURITIES

    Upload your portfolio for free, ask us

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search